Last updated on February 2018

Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III


Brief description of study

The principal goal of this study is to describe the epidemiology of breast cancer in the Brazilian population

Detailed Study Description

The principal goal of this study is to describe the epidemiology of breast cancer in the Brazilian population. Other specific goals are:

  • To evaluate the demographic and socio-demographic profile, comorbidities and reproductive risks, anthropometric profile and family history.
  • Characterize the breast tumors immunophenotype through anatomopathological data, such as: tumor grade, estrogen receptor, progesterone receptor, HER2, Ki67.
  • Describe the screening tests, main symptoms and cancer stage in the moment of the diagnosis.
  • Describe the initial cancer treatment and locally advanced such as surgery, radiotherapy, chemotherapy and endocrine therapy.
  • Describe palliative treatment for recurrent or metastatic breast cancer: chemotherapy, radiotherapy, biphosphonate, and others.
  • Evaluate the clinical outcomes such as: local or diffuse relapse, period of time until progression to metastatic cancer, global lifespan and specific breast cancer lifespan.
  • Evaluate clinical complications of the metastatic disease, such as: brain metastasis, spinal cord compression, skeletal related events.
  • Analyze the demographical and socio-economical characteristics, clinical-pathological characteristics of the tumor, treatment, clinical outcomes, type of institution (private/public), and other factors that may impact clinical outcome.

Clinical Study Identifier: NCT02663973

Contact Investigators or Research Sites near you

Start Over

Giuliano Borges, MD

Cl nica de Neoplasias Litoral - Centro de Novos Tratamentos Itaja
Itajaí, Brazil
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.